GPX3 and pulmonary fibrosis: In the mouse model of bleomycin-induced lung fibrosis, Gpx3 levels in tissue and BALF were increased in the inflammatory (day 3–7) and fibrotic (day 14–28) phase35, 46, but had returned to baseline after resolution of fibrosis at day 56.